• Mon, April 11, 2022
• Tue, April 12, 2022
Etzer Darout Maintained (CCCC) at Buy with Decreased Target to $20 on, Apr 11th, 2022
Etzer Darout of BMO Capital, Maintained "C4 Therapeutics, Inc." (CCCC) at Buy with Decreased Target from $57 to $20 on, Apr 11th, 2022.
Etzer has made no other calls on CCCC in the last 4 months.
There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Etzer's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Initiated at Hold and Held Target at $25 on, Thursday, February 10th, 2022
This is the rating of the analyst that currently disagrees with Etzer
- Eric Joseph of "JP Morgan" Initiated at Buy and Held Target at $43 on, Thursday, March 10th, 2022
